These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7527327)

  • 1. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
    Grant S; Fitton A
    Drugs; 1994 Aug; 48(2):253-73. PubMed ID: 7527327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
    He H; Richardson JS
    Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of risperidone in schizophrenia.
    Curtis VA; Kerwin RW
    Drug Saf; 1995 Feb; 12(2):139-45. PubMed ID: 7539272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL; Pathiraja AP; Diamond BI; Meibach RC
    Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
    Gupta S; Black DW; Smith DA
    Ann Clin Psychiatry; 1994 Sep; 6(3):173-80. PubMed ID: 7533585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone.
    Livingston MG
    Lancet; 1994 Feb; 343(8895):457-60. PubMed ID: 7508541
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone for chronic schizophrenia.
    Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical review of risperidone.
    Chouinard G; Arnott W
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone: review and assessment of its role in the treatment of schizophrenia.
    Cardoni AA
    Ann Pharmacother; 1995 Jun; 29(6):610-8. PubMed ID: 7545034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone: integrating research and practice.
    Addington D
    Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone.
    Cohen LJ
    Pharmacotherapy; 1994; 14(3):253-65. PubMed ID: 7524043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of risperidone.
    Ereshefsky L; Lacombe S
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
    Keegan D
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
    Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of risperidone on positive features of schizophrenia.
    McEvoy JP
    J Clin Psychiatry; 1994 May; 55 Suppl():18-21. PubMed ID: 7520904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone: clinical development: north American results.
    Marder SR
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():92A-93A. PubMed ID: 1379883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
    Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.